Does ENCORAFENIB Cause Rash maculo-papular? 51 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 51 reports of Rash maculo-papular have been filed in association with ENCORAFENIB (BRAFTOVI). This represents 0.6% of all adverse event reports for ENCORAFENIB.
51
Reports of Rash maculo-papular with ENCORAFENIB
0.6%
of all ENCORAFENIB reports
7
Deaths
34
Hospitalizations
How Dangerous Is Rash maculo-papular From ENCORAFENIB?
Of the 51 reports, 7 (13.7%) resulted in death, 34 (66.7%) required hospitalization, and 8 (15.7%) were considered life-threatening.
Is Rash maculo-papular Listed in the Official Label?
Yes, Rash maculo-papular is listed as a known adverse reaction in the official FDA drug label for ENCORAFENIB.
What Other Side Effects Does ENCORAFENIB Cause?
Death (1,004)
Off label use (989)
Nausea (758)
Fatigue (685)
Diarrhoea (574)
Neoplasm progression (548)
Pyrexia (539)
Product use in unapproved indication (506)
Vomiting (429)
Rash (414)
What Other Drugs Cause Rash maculo-papular?
SULFAMETHOXAZOLE\TRIMETHOPRIM (935)
AMOXICILLIN (871)
VANCOMYCIN (642)
PIPERACILLIN\TAZOBACTAM (629)
PANTOPRAZOLE (589)
LAMOTRIGINE (568)
ALLOPURINOL (550)
CARBOPLATIN (529)
ACETAMINOPHEN (499)
CLINDAMYCIN (484)
Which ENCORAFENIB Alternatives Have Lower Rash maculo-papular Risk?
ENCORAFENIB vs ENDOXAN
ENCORAFENIB vs ENDOXAN BAXTER
ENCORAFENIB vs ENDOXAN INJ
ENCORAFENIB vs ENDOXAN , POUDRE POUR
ENCORAFENIB vs ENFORTUMAB VEDOTIN